SEC Form 3 · accession 0001567619-19-000660
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan T Baldasare
Officer — Chief Accounting Officer
Period of report
Jan 1, 2019
Accepted (ET)
Jan 7, 2019 · 12:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 30,871 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.71 | holding | — | — | — | — | Aug 4, 2020 | Common Stock | 1,500 | — | D |
| Stock Option (Right to Buy)F2 | $19.56 | holding | — | — | — | — | Mar 24, 2026 | Common Stock | 15,000 | — | D |
Explanation of responses
- F1These non-qualified options were awarded under the 2004 Equity Compensation Plan and are fully vested and exercisable.
- F2These non-qualified options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on March 24, 2020)